4.3 Article

Cancer Survivors' Long-Term Health Service Costs in Queensland, Australia: Results of a Population-Level Data Linkage Study (Cos-Q)

Related references

Note: Only part of the references are listed.
Article Oncology

Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life Years for 29 Cancer Groups From 2010 to 2019 A Systematic Analysis for the Global Burden of Disease Study 2019

Jonathan M. Kocarnik et al.

Summary: The global burden of cancer is substantial and growing, with differences in burden based on Sociodemographic Index (SDI). The largest percentage increase in the numbers of cases and deaths occurred in the low and low-middle SDI quintiles from 2010 to 2019.

JAMA ONCOLOGY (2022)

Article Economics

Long-term cost of breast cancer treatment to the United States Medicare Program by stage at diagnosis

Ian Grady et al.

Summary: This study found that the 10-year treatment cost of female Medicare beneficiaries with breast cancer increases with increasing stage at diagnosis. Any effective screening technology that reduces stage at diagnosis will result in significant treatment cost savings to the Medicare program.

EUROPEAN JOURNAL OF HEALTH ECONOMICS (2021)

Article Economics

Economic burden of lung cancer in Turkey: a cost of illness study from payer perspective

Irfan Cicin et al.

Summary: This study estimated the economic burden of lung cancer in Turkey, revealing substantial and comparable direct medical costs for small cell lung cancer and non-small-cell lung cancer per patient. Hospitalization/interventions and indirect costs were identified as major cost drivers for total direct costs and the overall economic burden of lung cancer. The findings highlight the importance of improving cancer prevention and early diagnosis strategies to reduce costs and enhance treatment sustainability.

HEALTH ECONOMICS REVIEW (2021)

Review Economics

The Indirect Cost Burden of Cancer Care in Canada: A Systematic Literature Review

Nicolas Iragorri et al.

Summary: Cancer imposes a substantial health and economic burden on patients and caregivers in Canada. The indirect cost burden of cancer is considerable from the perspectives of patients, caregivers, employers, and society, encompassing factors such as lost earnings, caregiving time, household production losses, and patient leisure time. This comprehensive review highlights the importance of implementing support measures to help patients and caregivers cope with the impact of cancer and continue engaging in productive activities.

APPLIED HEALTH ECONOMICS AND HEALTH POLICY (2021)

Article Oncology

Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries

Hyuna Sung et al.

Summary: The global cancer burden in 2020 saw an estimated 19.3 million new cancer cases and almost 10.0 million cancer deaths. Female breast cancer surpassed lung cancer as the most commonly diagnosed cancer, while lung cancer remained the leading cause of cancer death. These trends are expected to rise in 2040, with transitioning countries experiencing a larger increase compared to transitioned countries due to demographic changes and risk factors associated with globalization and a growing economy. Efforts to improve cancer prevention measures and provision of cancer care in transitioning countries will be crucial for global cancer control.

CA-A CANCER JOURNAL FOR CLINICIANS (2021)

Article Oncology

Acute and late side-effects after low dose-rate brachytherapy for prostate cancer; incidence, management and technical considerations

Joelle Helou et al.

Summary: This study reviewed common reported side effects and complications after primary LDR-BT (monotherapy) and discussed some technical aspects that could impact treatment outcomes, finding that the learning curve and implant quality significantly influence toxicity outcomes, and that reducing technical challenges can decrease the incidence of side effects.

BRACHYTHERAPY (2021)

Article Medicine, General & Internal

Estimated Costs and Long-term Outcomes of Patients With High-Risk Non-Muscle-Invasive Bladder Cancer Treated With Bacillus Calmette-Guerin in the Veterans Affairs Health System

Stephen B. Williams et al.

Summary: Despite adequate induction BCG therapy, only 37% of patients received adequate BCG therapy. Patients with Cis had increased risk of progression, and progression regardless of Cis was associated with significantly increased costs relative to patients without progression. Extrapolating cost figures, regardless of progression, resulted in nationwide costs at 1 year of $373 million for patients diagnosed with high-risk NMIBC in 2019.

JAMA NETWORK OPEN (2021)

Article Environmental Sciences

First-Year Healthcare Resource Utilization Costs of Five Major Cancers in Japan

Tomone Watanabe et al.

Summary: This study analyzed the per-patient costs of five major cancers in Japan using cancer registry data and health service utilization data, showing that lung cancer had the highest healthcare cost per-patient, while breast cancer had the lowest. Colorectal cancer had the highest cost in the first month after diagnosis, and the gaps between costs of the five common cancers diminished over time.

INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH (2021)

Article Gastroenterology & Hepatology

The economic burden of colorectal cancer across Europe: a population-based cost-of-illness study

Raymond Hugo Henderson et al.

Summary: The economic burden of colorectal cancer in Europe in 2015 was 19.1 billion euros, with non-healthcare costs accounting for 60.6% of the total burden and healthcare costs accounting for 39.4%. The average cost of managing a patient with colorectal cancer varied widely between countries.

LANCET GASTROENTEROLOGY & HEPATOLOGY (2021)

Article Pharmacology & Pharmacy

The economic burden of metastatic breast cancer in Spain

Begona Bermejo de las Heras et al.

EUROPEAN JOURNAL OF HOSPITAL PHARMACY (2020)

Article Environmental Sciences

Lifetime Costs of Surviving Cancer-A Queensland Study (COS-Q): Protocol of a Large Healthcare Data Linkage Study

Katharina M. D. Merollini et al.

INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH (2020)

Review Oncology

The psychosocial cost burden of cancer: A systematic literature review

Beverley M. i Essue et al.

PSYCHO-ONCOLOGY (2020)

Article Health Care Sciences & Services

Horizontal inequity in the utilisation of healthcare services in Australia

Mohammad Habibullah Pulok et al.

HEALTH POLICY (2020)

Review Oncology

Late side effects of radiation treatment for head and neck cancer

Itzhak Brook

RADIATION ONCOLOGY JOURNAL (2020)

Article Economics

The economic burden of disease of epithelial ovarian cancer in Spain: the OvarCost study

Laura Delgado-Ortega et al.

EUROPEAN JOURNAL OF HEALTH ECONOMICS (2019)

Article Public, Environmental & Occupational Health

'Treat them into the grave': cancer physicians' attitudes towards the use of high-cost cancer medicines at the end of life

Miriam Wiersma et al.

SOCIOLOGY OF HEALTH & ILLNESS (2019)

Article Public, Environmental & Occupational Health

Long-term out of pocket expenditure of people with cancer: comparing health service cost and use for indigenous and non-indigenous people with cancer in Australia

Emily Callander et al.

INTERNATIONAL JOURNAL FOR EQUITY IN HEALTH (2019)

Article Multidisciplinary Sciences

Assessment of costs associated with adverse events in patients with cancer

William Wong et al.

PLOS ONE (2018)

Article Multidisciplinary Sciences

Health services costs for cancer care in Australia: Estimates from the 45 and Up Study

David E. Goldsbury et al.

PLOS ONE (2018)

Article Urology & Nephrology

Long-term costs and survival of prostate cancer: a population-based study

Valentin Brodszky et al.

INTERNATIONAL UROLOGY AND NEPHROLOGY (2017)

Article Oncology

Phase-specific and lifetime costs of cancer care in Ontario, Canada

Claire de Oliveira et al.

BMC CANCER (2016)

Article Urology & Nephrology

Economic Burden of Bladder Cancer Across the European Union

Jose Leal et al.

EUROPEAN UROLOGY (2016)

Editorial Material Oncology

Categorization of Cancer Survivors: Why We Need It

Antonella Surbone et al.

JOURNAL OF CLINICAL ONCOLOGY (2016)

Review Health Care Sciences & Services

The impact of chronic conditions on the economic burden of cancer survivorship: a systematic review

Sun Hee Rim et al.

EXPERT REVIEW OF PHARMACOECONOMICS & OUTCOMES RESEARCH (2016)

Article Oncology

Survivorship: Introduction and Definition

Crystal S. Denlinger et al.

JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK (2014)

Article Oncology

Economic Burden of Cancer Survivorship Among Adults in the United States

Gery P. Guy et al.

JOURNAL OF CLINICAL ONCOLOGY (2013)

Article Oncology

Economic burden of cancer across the European Union: a population-based cost analysis

Ramon Luengo-Fernandez et al.

LANCET ONCOLOGY (2013)

Article Economics

Comparing methodologies for the cost estimation of hospital services

S. S. Tan et al.

EUROPEAN JOURNAL OF HEALTH ECONOMICS (2009)

Article Oncology

Health behaviors of cancer survivors: data from an Australian population-based survey

Elizabeth G. Eakin et al.

CANCER CAUSES & CONTROL (2007)

Article Endocrinology & Metabolism

Long-term effects of androgen deprivation therapy in prostate cancer patients

S Basaria et al.

CLINICAL ENDOCRINOLOGY (2002)